ALIMERA SCIENCES INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Net revenue
Product
License
Total net revenue
Cost of goods sold, excluding depreciation and amortization
Gross profit
Operating expenses:
Research, development and medical affairs expenses
General and administrative expenses
Sales and marketing expenses
Depreciation and amortization
Total operating expenses
Loss from operations
Interest expense and other, net
Unrealized foreign currency gain, net
Change in fair value of common stock warrant
Change in fair value of warrant asset
Net loss before income taxes
Income tax provision
GAIN ON EXTINGUISHMENT OF PREFERRED STOCK
Net loss
WEIGHTED AVERAGE SHARES OUTSTANDING - Basic (in shares)
Preferred stock dividends
Net loss applicable to common stockholders
Net loss per share — basic
Net loss per share — diluted
WEIGHTED AVERAGE SHARES OUTSTANDING — Diluted (in shares)
Weighted average shares outstanding — Basic
Weighted average shares outstanding — Diluted

Comments